Otu n'ime ihe nchịkọta nri nke kachasị mụọ na ndị PCOS bụ inositol. O nwekwara ezigbo ihe kpatara ya: a gosipụtarala ụdị Myo (MYO) na d-Chiro-inositol (DCI) dị iche iche iji meziwanye ọtụtụ akụkụ metabolic na mmepụta nke PCOS. Uru ndị a gụnyere mmelite na cholesterol , insulin, androgens na ibu. Ụmụ nwanyị ndị na-enweta inositol na-enwe mmetụta ole na ole.
Karịsịa, a gosipụtara MYO iji mee ka ọmụmụ dịkwuo mma site na imezi àgwà ọma nke anụ ahụ ma weghachite oge izu ike na nke ọma dị ka belata ihe ize ndụ nke ọrịa shuga.
Ọ bụ ezie na ụdị MYO na DCI na-enye ọtụtụ nwanyị ndị nwere PCOS, nchọpụta ọhụrụ na-egosi ugbu a na ọ bụ nchikota nke ụdị abụọ ahụ, na usoro anụ ahụ nke na-egosi uru kachasị.
Kedu ihe bụ Inositol?
Inositol bụ onye so na B-vitamin na mpaghara nke akpụkpọ ahụ. Enositol dị na nri ndị dị ka mkpụrụ osisi, agwa, ọka, na mkpụrụ ma na-ahụkwa ahụ. Ọ bụ ezie na e nwere ụdị inositol itoolu, ọ bụ MYO na DCI ndị gosipụtara uru kachasị mma na PCOS. Nke ahụ bụ n'ihi na ekwenyere na ndị inyom nwere PCOS nwere ike inwe nkwarụ n'ikike ahụ mmadụ iji MYO na DCI, na-enye aka na nkwụsị insulin . MYO na DCI na-arụ ọrụ dịka ndị ozi nke abụọ na-agbasapụ ihe ngosi ndị metụtara iwu iwu insulin.
Uru nke Myo na d-chiro Inositol ejikọtara
MYO na DCI bụ mkpụrụ ndụ dị iche iche na-arụ ọrụ dị iche iche na ahụ.
A na-eme DCI site na MYO mgbe achọrọ . Ahụ na-akwado ụda plasma ọma MYO na DCI nke 40: 1. Onu ogugu MYO na DCI na mmiri ocha bu ihe kariri elu - 100: 1. Akwara na akwacyti oocytes nwere oke nke MYO.
Enweghi oke aha na MYI na DCI nwere ike imetuta onu ogugu.
Naanị mgbe a na-enye DCI nanị na akwa dosages (600-2400 mg kwa ụbọchị) a chọpụtara na ọ na-emetụ mma na-eme ka ọ dị mma ma na-emeghachi omume nwa nwanyị. Kedu ihe ọzọ, ọnụ ọgụgụ dị elu nke DCI (na ụfụ nke MYO na DCI), nke ka njọ na-eme ka ọ bụrụ na ọ ga-adị mma ma ọ bụrụ na ọ ga-eme ya.
ANYỊ edewo MYO nke ọma ka ọ bụrụ onye ka DCI ka ọ dị mma iji meziwanye nrụgide insulin, àgwà ọma nke anụ ma belata ihe ize ndụ maka ọrịa shuga gestation na ụmụ nwanyị nwere PCOS. Otú ọ dị, mgbe MYO jikọtara ya na DCI n'ime ntụle kacha mma, a na-ahụ nsonaazụ kacha mma.
N'ime nnyocha e bipụtara na magazin Archives nke Gynecology na Obstetrics , a na-emeso ndị inyom nwere PCOS na-ebu IVF ihe dịka MYO na DCI na nhazi physiologic nke 40: 1 ma ọ bụ 500 mg nke DCI nanị. Ngwakọta a jikọtara ọnụ nwere ike melite mmachi na na embrayo, yana oke ime, na-egosi na MYO na-arụ ọrụ dị oke mkpa na ovary na ụmụ nwanyị PCOS na uru nke MYO na DCI na nhazi kacha mma.
N'ọmụmụ ihe ọzọ e bipụtara n'afọ a na European Review maka Medical and Pharmacological Sciences , ụmụ nwanyị buru ibu na PCOS natara MYO na DCI ma ọ bụ MYO nanị maka ọnwa isii. Ná ngwụsị nke ọgwụgwọ ahụ, nkwonkwo ejikọta na MYO na DCI dị irè karị na mbenata akụkụ nke metabolic ma e jiri ya tụnyere òtù MYO.
Ndị dere kwubiri na "a ga-ewere usoro nchịkwa nke MI na DCI na nchịkwa plasma physiological (40: 1) dị ka ụzọ mbụ na PCOS.
Kedu ihe ị ga-eji mara banyere ịmịnye ọrịa?
A na-atụ aro na ndị inyom nwere PCOS ga - ejikọta MYO (2-4 grams) na DCI (50-100mg) n'ọdịdị physiologic 40: 1.
N'ozuzu, MYO na DCI nabatara nke ọma kama ọ nwere ike ibute shuga shuga , karịsịa ma ọ bụrụ na ịṅụ ọgwụ ma ọ bụ ihe mgbakwunye ndị ọzọ nke belata ọbara shuga. Dị ka mgbe niile, lelee dọkịta gị tupu ịmalite inositol.
> Isi mmalite:
> Costantino D, Minozzi G, Minozzi E, Guaraldi C. Metabolic na Hormonal Effects of Myoinositol in Women with Polycystic Ovary Syndrome: a Ịhụ Ọhụhụ Abụọ. Europ Review Med Pharmacol Sci . 2009; 13 (2): 105-110.
> Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S. Myo-Inositol Kama D-Chiro-Inositol Ga-eme Ka Mma Nwee Ọganihu na Intanet na IntracyToplasmic Sperm Injection. Achọpụta, Na-achịkwa, Nchọpụta Rịpụtara. Europ Review Med Pharmacol Sci. 2011; 15 (4): 452-457.
> Le Donne M, Alibrandi A, Giarrusso R, Mona Mona I, Muraca U. [Diet, Metformin and Inositol in Overweight and Obese Women with Polycystic Ovary Syndrome: Effects on Body Composition]. Minerva Ginecologica. 2012; 64 (1): 23-29.
> Venturella R, Mocciaro R, De Trana E, D'Alessandro P, Morelli M, Zullo F. [Nyochaa nke Mgbanwe nke Ahụike, Endocrinal na Metabolical Profaịlụ nke Ndị Ọrịa na PCOS Ọrịa Na-emeso MYO-Inositol]. Minerva Ginecologica. 2012; 64 (3): 239-243.
> Genazzani AD, Prati A, Santagni S, et al. Ntinye insulin dị iche iche na nchịkwa Myo-Inositol na Obese Polycystic Ovary Syndrome Patients. Gynecol Endocrinol. 2012; 28 (12): 969-973.
> Gerli S, Papaleo E, Ferrari A, Di Renzo GC. Ebumnuche, Nyocha abụọ a na-ejide n'ọnwa: Mmetụta Myo-Inositol na Ovarian Function na Metabolic Ihe na Ụmụ nwanyị na PCOS. Europ Rev Med Pharmacol Sci . 2007; 11 (5): 347-354.
> Raffone E, Rizzo P, Benedetto V. Insulin Sensitiser Agents Alone na Co-Treatment na r-FSH maka Nwunye Nwunye na PCOS Women. Gynecol Endocrinol. 2010; 26 (4): 275-280.
> Galazis N, Galazi M, Atiomo W. D-Chiro-Inositol na Ihe Ọrịta Ya na Polycystic Ovary Syndrome: a Review System. Gynecol Endocrinol . 2011; 27 (4): 256-62
> Papaleo, E., Unfer, V., Baillargeon, JP, et al. (2007). Myo-Inositol in Patients with Polycystic Ovary Syndrome: Ụzọ Ọhụụ Maka Ntughari Ovulation. Gynecological Endocrinology, 23 (12): 700-703.
> D 'Anna R, Di Benedetto V, Rizzo P, et al. MYO-Inositol nwere ike igbochi ọrịa shuga na-emegharị ahụ na ụmụ nwanyị PCOS. Gynecol Endocrinol. 2012; 28 (6): 440-442.
> Isabella R, Raffone E. Ndi Ovary Achọrọ D-Chiro-Inositol? J Ovarian Res. 2012 Mee 15; 5 (1): 14.
> Dinicola S1, Chiu TT, Unfer V, Carlomagno G, Bizzarri M. Rationale nke Myoinositol na D-Chiro-Inositol Njikọ Ejikọtara Maka Ọrịa Oko na Polycystic. J Clin Pharmacol. 2014 Ọkt; 54 (10): 1079-92.
> Nordio M, Proietti E. Ngwakọta Ejikọtara Ya na Myoinositol na D-Chiro-Inositol Na-ebelata Ọdachi Metabolic na PCOS Overweight Patients Tụfuru na Myoinositol Mmezi Naanị. Eur Rev Med Pharmacol Sci. 2012 May, 16 (5): 575-81.
> Colazingari S, Treglia M, Najjar R, Bevilacqua A. Ọrịa Na-ejikọta Aka Myoinositol Plus D-Chiro-Inositol, Karịa D-Chiro-Inositol, Pụrụ Inwe Mmelite Ọganihu IVF: Nsonaazụ site na Nchọpụta Controlled Control. Arch Gynecol Obstet. 2013 Dec; 288 (6): 1405-11.